Skip to main content

Research Repository

Advanced Search

HLA-C*06:02 allele is associated with higher drug survival in patients with psoriasis on ustekinumab: an analysis from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR), on behalf of the BADBIR and BSTOP study groups

Alabas, O.; Mason, K.; Yiu, Z.; Warren, R.; Dand, N.; Barker, J.; Smith, C.; Griffiths, C

Authors

O. Alabas

Z. Yiu

R. Warren

N. Dand

J. Barker

C. Smith

C Griffiths



Citation

Alabas, O., Mason, K., Yiu, Z., Warren, R., Dand, N., Barker, J., Smith, C., & Griffiths, C. HLA-C*06:02 allele is associated with higher drug survival in patients with psoriasis on ustekinumab: an analysis from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR), on behalf of the BADBIR and BSTOP study groups. Presented at Psoriasis: From Gene to Clinic, 9th International Congress, The Queen Elizabeth II Conference Centre, London

Presentation Conference Type Conference Abstract
Conference Name Psoriasis: From Gene to Clinic, 9th International Congress
Acceptance Date Jan 1, 2022
Publication Date Jan 1, 2022
Deposit Date Jun 12, 2023
Journal British Journal of Dermatology (BJD)
Print ISSN 0007-0963
Electronic ISSN 1365-2133
Publisher Wiley
Peer Reviewed Peer Reviewed
Volume 186
Issue 1
Pages e8-e9
Public URL https://keele-repository.worktribe.com/output/444868
Publisher URL https://academic.oup.com/bjd/article/186/1/e2/6593592


You might also like



Downloadable Citations